Facing regulatory pressures, resource constraints, and changing health care industry, the medtech industry must redefine innovation to deliver value for payers and patients. Read more.
Pulse of the industry - medical technology report 2013
The shifting pharmaceutical industry landscape
Cash on prescription 2013
Beyond Borders: global biotech report 2013
Life Sciences deal sentiment scorecard
mHealth: Mobile tech poised to enable new era in health care
Cash on the prescription 2012
Beyond borders: global biotech report 2012
Pharma's $100 billion growth gap
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm in today’s environment of rapid change in health care.
The life sciences community must explore a new course to address the changing climate — one driven by patients and focused on health outcomes.
From new market entrants and regulatory reform to expiring patents and rising prevalence of chronic disease, there are a myriad of hurdles to overcome.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas:
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
Conversations in health care, a special edition, features interviews with health care leaders from around the world.